Logo for Cessatech

Cessatech Investor Relations Material

Latest events

Logo for Cessatech

Q4 2024

28 Feb, 2025
Logo for Cessatech

Q3 2024

13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Cessatech

Access all reports
Cessatech A/S is a biopharmaceutical company dedicated to identifying, developing and commercializing drugs for children with the potential to treat cancer and fibrotic disorders. The company's focus of research and development is based on the proteins in regulatory T-cells (Tregs) that suppress an immune system response to secondary disease processes, such as cancer and fibrosis.